MAb HMN14 Uses, Dosage, Side Effects and more
MAb HMN14 is a humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth. It is used in radioimmunotherapy.
| Trade Name | MAb HMN14 |
| Generic | Labetuzumab |
| Labetuzumab Other Names | hMN-14, Labetuzumab, MAb hMN14, Monoclonal antibody hMN-14 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
MAb HMN14 is a humanized monoclonal antibody used to treat cancer. Retrieved from "http://en.wikipedia.org/wiki/MAb HMN14"
How MAb HMN14 works
labetuzumab could significantly increase the chemosensitivity of human colon and breast cancer cells in vitro to several anticancer drugs.
